RecallDepth
Class I Terminated

Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

This recall has been terminated (originally issued August 3, 2022).

Company
Pfizer Inc.
Recall Initiated
July 13, 2022
Posted
August 3, 2022
Recall Number
D-1301-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54,000 vials
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of particulate matter: particulate identified as a beetle.

Distribution

USA Nationwide

Lot / Code Info

Lot #: DX9067, Exp 5/1/2023

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class I Drug recalls